Published in Biochem Pharmacol on April 24, 2009
GLO1 overexpression in human malignant melanoma. Melanoma Res (2010) 0.99
DCPIP (2,6-dichlorophenolindophenol) as a genotype-directed redox chemotherapeutic targeting NQO1*2 breast carcinoma. Free Radic Res (2010) 0.93
The redox antimalarial dihydroartemisinin targets human metastatic melanoma cells but not primary melanocytes with induction of NOXA-dependent apoptosis. Invest New Drugs (2011) 0.91
Thiostrepton is an inducer of oxidative and proteotoxic stress that impairs viability of human melanoma cells but not primary melanocytes. Biochem Pharmacol (2012) 0.88
Inhibition of angiogenesis- and inflammation-inducing factors in human colon cancer cells in vitro and in ovo by free and nanoparticle-encapsulated redox dye, DCPIP. J Nanobiotechnology (2010) 0.88
D-Penicillamine targets metastatic melanoma cells with induction of the unfolded protein response (UPR) and Noxa (PMAIP1)-dependent mitochondrial apoptosis. Apoptosis (2012) 0.84
Phenotypic identification of the redox dye methylene blue as an antagonist of heat shock response gene expression in metastatic melanoma cells. Int J Mol Sci (2013) 0.81
The quinone methide aurin is a heat shock response inducer that causes proteotoxic stress and Noxa-dependent apoptosis in malignant melanoma cells. J Biol Chem (2014) 0.77
The Ontogeny and Population Variability of Human Hepatic NADPH Dehydrogenase Quinone Oxido-Reductase 1 (NQO1). Drug Metab Dispos (2016) 0.75
Protonation and electronic structure of 2,6-dichlorophenolindophenolate during reduction. A theoretical study including explicit solvent. J Mol Model (2016) 0.75
Reactive oxygen species: a breath of life or death? Clin Cancer Res (2007) 4.20
Photoreduction and photophosphorylation with tris-washed chloroplasts. Plant Physiol (1968) 3.57
Controlling tumor growth by modulating endogenous production of reactive oxygen species. Cancer Res (2005) 3.12
The transcription factor Egr1 is a direct regulator of multiple tumor suppressors including TGFbeta1, PTEN, p53, and fibronectin. Cancer Gene Ther (2006) 2.24
NAD(P)H:quinone oxidoreductase 1 NQO1*2 genotype (P187S) is a strong prognostic and predictive factor in breast cancer. Nat Genet (2008) 2.18
Intrinsic oxidative stress in cancer cells: a biochemical basis for therapeutic selectivity. Cancer Chemother Pharmacol (2003) 1.99
NAD(P)H:quinone oxidoreductase 1 (NQO1, DT-diaphorase), functions and pharmacogenetics. Methods Enzymol (2004) 1.97
mda-7 (IL-24) Mediates selective apoptosis in human melanoma cells by inducing the coordinated overexpression of the GADD family of genes by means of p38 MAPK. Proc Natl Acad Sci U S A (2002) 1.91
Menadione-induced reactive oxygen species generation via redox cycling promotes apoptosis of murine pancreatic acinar cells. J Biol Chem (2006) 1.82
The in vivo gene expression signature of oxidative stress. Physiol Genomics (2008) 1.55
An NAD(P)H oxidase regulates growth and transcription in melanoma cells. Am J Physiol Cell Physiol (2002) 1.55
A lack of a functional NAD(P)H:quinone oxidoreductase allele is selectively associated with pediatric leukemias that have MLL fusions. United Kingdom Childhood Cancer Study Investigators. Cancer Res (1999) 1.49
Melanoma genetics and therapeutic approaches in the 21st century: moving from the benchside to the bedside. J Invest Dermatol (2008) 1.49
Platinums sensitize human epithelial tumor cells to lymphotoxin alpha by inhibiting NFkappaB-dependent transcription. Cancer Biol Ther (2008) 1.44
Molecular pharmacology and pharmacogenomics of artemisinin and its derivatives in cancer cells. Curr Drug Targets (2006) 1.40
Plumbagin induces cell cycle arrest and apoptosis through reactive oxygen species/c-Jun N-terminal kinase pathways in human melanoma A375.S2 cells. Cancer Lett (2007) 1.39
Experimental therapeutics: targeting the redox Achilles heel of cancer. Curr Opin Investig Drugs (2007) 1.38
Disulfiram facilitates intracellular Cu uptake and induces apoptosis in human melanoma cells. J Med Chem (2004) 1.35
The reactive oxygen-driven tumor: relevance to melanoma. Pigment Cell Melanoma Res (2008) 1.31
Elesclomol induces cancer cell apoptosis through oxidative stress. Mol Cancer Ther (2008) 1.24
Human tumor models in the severe combined immune deficient (scid) mouse. Cancer Chemother Pharmacol (1997) 1.20
Artesunate in the treatment of metastatic uveal melanoma--first experiences. Oncol Rep (2005) 1.19
DT-diaphorase: a target for new anticancer drugs. Cancer Treat Rev (2004) 1.19
Targeting NAD(P)H:quinone oxidoreductase (NQO1) in pancreatic cancer. Mol Carcinog (2005) 1.18
NQO1-activated phenothiazinium redox cyclers for the targeted bioreductive induction of cancer cell apoptosis. Free Radic Biol Med (2007) 1.16
Mechanistic perspectives for 1,2,4-trioxanes in anti-cancer therapy. Drug Resist Updat (2005) 1.16
Motexafin gadolinium: a novel redox active drug for cancer therapy. Semin Cancer Biol (2006) 1.13
The cinnamon-derived Michael acceptor cinnamic aldehyde impairs melanoma cell proliferation, invasiveness, and tumor growth. Free Radic Biol Med (2008) 1.10
In vitro biological characterization of a novel, synthetic diaryl pyrazole resorcinol class of heat shock protein 90 inhibitors. Cancer Res (2007) 1.07
Induction of heat shock proteins in differentiated human and rodent neurons by celastrol. Cell Stress Chaperones (2007) 1.07
Sequential oxidation and glutathione addition to 1,4-benzoquinone: correlation of toxicity with increased glutathione substitution. Mol Pharmacol (1988) 1.07
Oxidative stress by ascorbate/menadione association kills K562 human chronic myelogenous leukaemia cells and inhibits its tumour growth in nude mice. Biochem Pharmacol (2006) 1.06
Reactive oxygen species in melanoma and its therapeutic implications. Melanoma Res (2007) 1.02
Hsp70B' and Hsp72 form a complex in stressed human colon cells and each contributes to cytoprotection. Exp Cell Res (2008) 1.01
Curcumin-induced GADD153 gene up-regulation in human colon cancer cells. Carcinogenesis (2004) 1.01
Epidermal growth factor receptor is a common mediator of quinone-induced signaling leading to phosphorylation of connexin-43: role of glutathione and tyrosine phosphatases. J Biol Chem (2003) 1.00
Determination of oxidation-reduction potentials. Methods Enzymol (1978) 0.99
Reactive oxygen species: an Achilles' heel of melanoma? Expert Rev Anticancer Ther (2008) 0.99
Dimethylfumarate impairs melanoma growth and metastasis. Cancer Res (2006) 0.98
Antimelanoma activity of apoptogenic carbonyl scavengers. J Pharmacol Exp Ther (2005) 0.93
Oxidative stress plays a critical role in inactivating mutant BRAF by geldanamycin derivatives. Cancer Res (2008) 0.92
Phase I trial of high dose paracetamol and carmustine in patients with metastatic melanoma. Melanoma Res (2003) 0.90
Reactive oxygen species may have antitumor activity in metastatic melanoma. J Natl Cancer Inst (2007) 0.89
Apoptosis/necrosis switch in two different cancer cell lines: influence of benzoquinone- and hydrogen peroxide-induced oxidative stress intensity, and glutathione. Toxicol In Vitro (2008) 0.88
Biochemical mechanism of acetaminophen (APAP) induced toxicity in melanoma cell lines. J Pharm Sci (2009) 0.88
NRP/B mutations impair Nrf2-dependent NQO1 induction in human primary brain tumors. Oncogene (2008) 0.87
2,6-Dichloro-phenol indophenol prevents switch-over of electrons between the cyanide-sensitive and -insensitive pathway of the mitochondrial electron transport chain in the presence of inhibitors. Anal Biochem (1999) 0.82
Ascorbate in plasma as measured by liquid chromatography and by dichlorophenolindophenol colorimetry. Clin Chem (1986) 0.82
The putative benzene metabolite 2,3, 5-tris(glutathion-S-yl)hydroquinone depletes glutathione, stimulates sphingomyelin turnover, and induces apoptosis in HL-60 cells. Chem Res Toxicol (2000) 0.81
In silico identification and biochemical characterization of novel inhibitors of NQO1. Bioorg Med Chem Lett (2006) 0.81
Conjugation of 2,6-dichloroindophenol with mitochondrial thiol groups. J Biol Chem (1966) 0.80
Discriminating redox cycling and arylation pathways of reactive chemical toxicity in trout hepatocytes. Toxicol Sci (2003) 0.80
Investigation by amperometric methods of intracellular reduction of 2,6-dichlorophenolindophenol in normal and transformed hepatocytes in the presence of different inhibitors of cellular metabolism. Biochim Biophys Acta (1990) 0.78
Multifunctional redox catalysts as selective enhancers of oxidative stress. Org Biomol Chem (2005) 0.78
Immunohistochemical localization of NAD(P)H:quinone oxidoreductase in conjunctival melanomas and primary acquired melanosis. Curr Eye Res (2001) 0.77
NAD(P)H:quinone oxidoreductase (NQO1) loss of function in Burkitt's lymphoma cell lines. Biofactors (2008) 0.77
Nonenzymatic NADPH-dependent reduction of 2,6-dichlorophenol-indophenol. Anal Biochem (1990) 0.76
Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2. Carcinogenesis (2008) 3.19
Therapeutic potential of Nrf2 activators in streptozotocin-induced diabetic nephropathy. Diabetes (2011) 2.03
Experimental therapeutics: targeting the redox Achilles heel of cancer. Curr Opin Investig Drugs (2007) 1.38
Tanshinone I activates the Nrf2-dependent antioxidant response and protects against As(III)-induced lung inflammation in vitro and in vivo. Antioxid Redox Signal (2013) 1.11
The cinnamon-derived Michael acceptor cinnamic aldehyde impairs melanoma cell proliferation, invasiveness, and tumor growth. Free Radic Biol Med (2008) 1.10
The cinnamon-derived dietary factor cinnamic aldehyde activates the Nrf2-dependent antioxidant response in human epithelial colon cells. Molecules (2010) 1.03
HDAC6 and SIRT2 regulate the acetylation state and oncogenic activity of mutant K-RAS. Mol Cancer Res (2013) 1.03
The experimental chemotherapeutic N6-furfuryladenosine (kinetin-riboside) induces rapid ATP depletion, genotoxic stress, and CDKN1A(p21) upregulation in human cancer cell lines. Biochem Pharmacol (2008) 1.02
GLO1 overexpression in human malignant melanoma. Melanoma Res (2010) 0.99
The topical antimicrobial zinc pyrithione is a heat shock response inducer that causes DNA damage and PARP-dependent energy crisis in human skin cells. Cell Stress Chaperones (2009) 0.99
The Nrf2-inducers tanshinone I and dihydrotanshinone protect human skin cells and reconstructed human skin against solar simulated UV. Redox Biol (2013) 0.96
Resveratrol prevents epigenetic silencing of BRCA-1 by the aromatic hydrocarbon receptor in human breast cancer cells. J Nutr (2010) 0.93
DNA damage by carbonyl stress in human skin cells. Mutat Res (2003) 0.93
DCPIP (2,6-dichlorophenolindophenol) as a genotype-directed redox chemotherapeutic targeting NQO1*2 breast carcinoma. Free Radic Res (2010) 0.93
The malondialdehyde-derived fluorophore DHP-lysine is a potent sensitizer of UVA-induced photooxidative stress in human skin cells. J Photochem Photobiol B (2010) 0.91
The redox antimalarial dihydroartemisinin targets human metastatic melanoma cells but not primary melanocytes with induction of NOXA-dependent apoptosis. Invest New Drugs (2011) 0.91
The antimalarial amodiaquine causes autophagic-lysosomal and proliferative blockade sensitizing human melanoma cells to starvation- and chemotherapy-induced cell death. Autophagy (2013) 0.89
Proteomic identification of cathepsin B and nucleophosmin as novel UVA-targets in human skin fibroblasts. Photochem Photobiol (2010) 0.88
Thiostrepton is an inducer of oxidative and proteotoxic stress that impairs viability of human melanoma cells but not primary melanocytes. Biochem Pharmacol (2012) 0.88
Zinc pyrithione impairs zinc homeostasis and upregulates stress response gene expression in reconstructed human epidermis. Biometals (2011) 0.85
D-Penicillamine targets metastatic melanoma cells with induction of the unfolded protein response (UPR) and Noxa (PMAIP1)-dependent mitochondrial apoptosis. Apoptosis (2012) 0.84
Autophagic-lysosomal dysregulation downstream of cathepsin B inactivation in human skin fibroblasts exposed to UVA. Photochem Photobiol Sci (2011) 0.81
Phenotypic identification of the redox dye methylene blue as an antagonist of heat shock response gene expression in metastatic melanoma cells. Int J Mol Sci (2013) 0.81
Nrf2 modulates contractile and metabolic properties of skeletal muscle in streptozotocin-induced diabetic atrophy. Exp Cell Res (2013) 0.81
UVA causes dual inactivation of cathepsin B and L underlying lysosomal dysfunction in human dermal fibroblasts. J Photochem Photobiol B (2013) 0.80
Plant extracts of the family Lauraceae: a potential resource for chemopreventive agents that activate the nuclear factor-erythroid 2-related factor 2/antioxidant response element pathway. Planta Med (2014) 0.78
HMGB1-directed drug discovery targeting cutaneous inflammatory dysregulation. Curr Drug Metab (2010) 0.76